IDEXX Laboratories Inc (IDXX)
418.55
-0.06
(-0.01%)
USD |
NASDAQ |
Nov 21, 16:00
428.99
+10.44
(+2.49%)
After-Hours: 05:09
IDEXX Laboratories Gross Profit Margin (Quarterly): 61.10% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.10% |
| June 30, 2024 | 61.70% |
| March 31, 2024 | 61.52% |
| December 31, 2023 | 58.36% |
| September 30, 2023 | 59.85% |
| June 30, 2023 | 60.71% |
| March 31, 2023 | 60.32% |
| December 31, 2022 | 58.53% |
| September 30, 2022 | 60.19% |
| June 30, 2022 | 59.73% |
| March 31, 2022 | 59.62% |
| December 31, 2021 | 56.98% |
| September 30, 2021 | 58.36% |
| June 30, 2021 | 59.23% |
| March 31, 2021 | 60.53% |
| December 31, 2020 | 56.80% |
| September 30, 2020 | 58.55% |
| June 30, 2020 | 59.50% |
| March 31, 2020 | 57.41% |
| December 31, 2019 | 54.70% |
| September 30, 2019 | 56.99% |
| June 30, 2019 | 57.71% |
| March 31, 2019 | 57.56% |
| December 31, 2018 | 54.67% |
| September 30, 2018 | 56.04% |
| Date | Value |
|---|---|
| June 30, 2018 | 57.24% |
| March 31, 2018 | 56.37% |
| December 31, 2017 | 53.84% |
| September 30, 2017 | 55.69% |
| June 30, 2017 | 57.51% |
| March 31, 2017 | 55.88% |
| December 31, 2016 | 54.32% |
| September 30, 2016 | 55.04% |
| June 30, 2016 | 55.84% |
| March 31, 2016 | 54.49% |
| December 31, 2015 | 54.47% |
| September 30, 2015 | 55.19% |
| June 30, 2015 | 56.31% |
| March 31, 2015 | 56.35% |
| December 31, 2014 | 51.76% |
| September 30, 2014 | 55.63% |
| June 30, 2014 | 56.01% |
| March 31, 2014 | 56.11% |
| December 31, 2013 | 53.28% |
| September 30, 2013 | 54.92% |
| June 30, 2013 | 56.07% |
| March 31, 2013 | 55.40% |
| December 31, 2012 | 52.90% |
| September 30, 2012 | 54.09% |
| June 30, 2012 | 55.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
54.70%
Minimum
Dec 2019
61.70%
Maximum
Jun 2024
59.18%
Average
59.56%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies Inc | 54.18% |
| Bio-Rad Laboratories Inc | 54.78% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| West Pharmaceutical Services Inc | 35.44% |
| NovaBay Pharmaceuticals Inc | 65.26% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 57.37% |
| Return on Assets | 26.30% |
| Return on Invested Capital | 35.27% |
| Profit Margin (Quarterly) | 23.87% |
| Operating Margin (Quarterly) | 31.15% |
| Return on Net Operating Assets | 37.38% |